A COMPARISON OF THE EFFICACY AND SAFETY OF THE DORZOLAMIDE/TIMOLOL FIXED COMBINATION GIVEN TWICE DAILY VERSUS THE LATANOPROST/TIMOLOL FIXED COMBINATION GIVEN ONCE EVERY MORNING FOLLOWING A RUN-IN PERIOD WITH TIMOLOL GIVEN ONCE DAILY

Trial Profile

A COMPARISON OF THE EFFICACY AND SAFETY OF THE DORZOLAMIDE/TIMOLOL FIXED COMBINATION GIVEN TWICE DAILY VERSUS THE LATANOPROST/TIMOLOL FIXED COMBINATION GIVEN ONCE EVERY MORNING FOLLOWING A RUN-IN PERIOD WITH TIMOLOL GIVEN ONCE DAILY

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2014

At a glance

  • Drugs Dorzolamide/timolol (Primary) ; Latanoprost/timolol; Timolol
  • Indications Exfoliation syndrome; Ocular hypertension; Open-angle glaucoma; Pigmentary glaucoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top